Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07183644 · ClinicalTrials.gov registry record · NA
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT07183644: Recruiting NA study, sponsored by University of Texas Southwestern Medical Center.
NCT07183644 is a NA study that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07183644, a NA study, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
In this study the investigators aim to optimize Port-Wine-Birthmark (PBW) laser therapy in children in order to reduce the number of laser treatments required for clearance and improve outcomes for refractory cases. This approach also seeks to reduce the frequency with which children require general anesthesia for treatment.
Primary Outcome
Prior to treatment, the PWB will be documented photographically. Images taken will be transformed in to the L a\*b\* colorspace (also known as the red green color axis), and regions of interest defined on the photographs corresponding with the areas treated by each modality, as well as a region of interest adjacent to the treated area, to act as a control to correct for skin changes unrelated to the treatment. The axis is representative of color chromaticity and is measured in a range of -128 to
Interventions
- DEVICE Pulse Dye laser
- DEVICE Pulse Dye Laser (PDL) pulse width stacking
- DEVICE Pulse Dye Laser (PDL) followed by Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet laser) laser.
- DEVICE IPL (Intense Pulsed Light) followed by Pulse Dye Laser (PDL)
- DEVICE Cupping followed by Pulse Dye Laser (PDL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-09 |
| Phase | NA |
What NCT07183644 shows while recruiting
NCT07183644 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 5 interventions - of which Pulse Dye laser is the first listed.
NCT07183644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07183644 about?
NCT07183644 is a clinical study titled "Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients". In this study the investigators aim to optimize Port-Wine-Birthmark (PBW) laser therapy in children in order to reduce the number of laser treatments required for clearance and improve outcomes for refractory cases. This approach also seeks to reduce the frequency with which children require general...
What is the current status of trial NCT07183644?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-07. Estimated completion is 2028-09.
What interventions are being tested in trial NCT07183644?
The interventions under investigation include: Pulse Dye laser (DEVICE), Pulse Dye Laser (PDL) pulse width stacking (DEVICE), Pulse Dye Laser (PDL) followed by Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet laser) laser. (DEVICE), IPL (Intense Pulsed Light) followed by Pulse Dye Laser (PDL) (DEVICE), Cupping followed by Pulse Dye Laser (PDL) (DEVICE).
Who is sponsoring clinical trial NCT07183644?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07183644's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia